NCT04164836 is a NA clinical trial of rhinoscope in Nasotracheal Intubation, sponsored by Ajou University School of Medicine.

Who is sponsoring NCT04164836?

NCT04164836 is sponsored by Ajou University School of Medicine.

What drugs are being tested in NCT04164836?

Interventions in NCT04164836: rhinoscope.

What condition does NCT04164836 study?

NCT04164836 studies Nasotracheal Intubation.

Is NCT04164836 still recruiting?

NCT04164836 is currently completed. Last updated 26 July 2022.

Last reviewed 2022-07-26 · How we verify

NCT04164836

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Nose Selection Using Rhnoscope on Epistaxis of Nasotracheal Intubation

Completed NA Last updated 26 July 2022

What this trial tests

NA trial testing rhinoscope in Nasotracheal Intubation in 182 participants. Completed in 30 March 2022.

Timeline

26 November 2019

Primary endpoint
30 March 2022

30 March 2022

Quick facts

Lead sponsor	Ajou University School of Medicine
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	diagnostic
Enrollment	182
Start date	26 November 2019
Primary completion	30 March 2022
Estimated completion	30 March 2022
Sites	1 location across South Korea

Drugs / interventions tested

rhinoscope

Conditions studied

Nasotracheal Intubation — all drugs for Nasotracheal Intubation →

Sponsor

Ajou University School of Medicine

Who can join

Adults 19 to 70, any sex, with Nasotracheal Intubation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Rhinoscope is useful to exam intranasal structure. This information could be utilized to select more suitable nose for nasotracheal intubation. Nastoracheal intubation using more patent nose could be associated with decrease of the development of epistaxis which is most common complication in nasotracheal intubation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Nasotracheal Intubation

Currently open trials in the same condition.

NCT06605989 — Nostril Side on Epistaxis · NA · recruiting

Other Ajou University School of Medicine trials

Trials by the same sponsor.

NCT07101380 — Feasibility Study of 'SuperBrain BOOM' for Mild Cognitive Impairment Patients · NA · recruiting
NCT07395752 — Youth Suicide and Self-Harm Intervention: Clinical and Biological Outcomes Study · NA · recruiting
NCT06964217 — Immediate Fracture Risk After Antihypertensive Drug Initiation · not yet recruiting
NCT05751603 — Effectiveness on Smooth Extubation According to the Administration Time of Sugammadex · NA · not yet recruiting
NCT07479160 — Heart to Heart Web-based Communication Program for Heart Failure · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04164836 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ajou University School of Medicine
Last refreshed: 26 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04164836.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing